Innovation
1 December 202413.3 min readBased originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.
21 November 20239 min readWe spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.
13 November 20235.6 min readTo celebrate Global Entrepreneurship Week, Dr Joanna Mills tells us what Entrepreneurship looks like at the Sanger Institute.
12 September 20238.3 min readThe Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.
23 March 202315.1 min readIn this third part of our innovator blog series, we spoke to Matt Hurles, Head of the Human Genetics programme and incoming Director of the Wellcome Sanger Institute. Matt defines himself as an accidental entrepreneur, even though he spearheads a number of innovative initiatives that showcase his motivation to ultimately bring benefits to patients.
9 February 202321.4 min readAs part of our innovator blog series, we spoke to Qianxin Wu who works jointly in our Cellular Genetics programme and our Cellular and Gene Editing R&D team. Qianxin is at the forefront of innovation, working on CRISPR, genome editing and single-cell technologies.
9 November 202217.1 min readWe talk to Physilia Chua about her work to monitor biodiversity and make DNA sequencing more accessible.
